COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.
A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.
Have Actionable Intelligence to support the development of your candidate through its clinical development journey
Measure your brand among others in the competitive arena you occupy.